Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Brigham and Women's Hospital
Case Comprehensive Cancer Center
Nurix Therapeutics, Inc.
Arcus Biosciences, Inc.
Washington University School of Medicine
Seagen Inc.
Celldex Therapeutics
Fate Therapeutics
Genzada Pharmaceuticals USA, Inc.
Ascentage Pharma Group Inc.
Hospital Universitario San Ignacio
Eutilex
Incyte Corporation
Hospices Civils de Lyon
Incyte Corporation
Shenzhen Geno-Immune Medical Institute
MultiVir, Inc.
Shenzhen BinDeBio Ltd.
University of California, San Diego
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Cancer Research UK
Case Comprehensive Cancer Center